VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 4D is what we were waiting 🚀🚀$$$

<< Previous

Bullboard Posts

Next >>

Comment by GrahamBon Sep 15, 2022 11:39am

80 Views

Post# 34964542

RE:RE:RE:RE:RE:RE:RE:4D is what we were waiting 🚀🚀$$$

Actually, in the reference that I have given, there is no statistical difference between the two modalities, using a students tea test at a P value of. 05-
in other words any difference is entirely due to chance.

Bottom line, it looks like , IMO,GE does have a competitive product in some areas, are developing artificial intelligence actively, and there is no evidence yet that VPT had been integrated after over a year.

No sales-zero-on published financials.

When will sales come?

Can you state a date when sales will happen?

(So far no one has been right)

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?